Article info

This article has a correction. Please see:

Download PDFPDF
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response
  1. Dr Ronald F van Vollenhoven, Department of Rheumatology, D2:01, Karolinska University Hospital, Solna, S-171 76 Stockholm, Sweden; ronald.van.vollenhoven{at}ki.se
View Full Text

Citation

Jónsdóttir T, Gunnarsson I, Risselada A, et al
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response

Publication history

  • Accepted September 2, 2007
  • First published September 7, 2007.
Online issue publication 
February 21, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.